Stock ACHFF ARCH BIOPARTNERS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Arch Biopartners Inc.

Equities

ACHFF

CA03938C1041

Delayed OTC Markets
Other stock markets
 02:27:19 2024-05-03 pm EDT 		5-day change 1st Jan Change
1.31 USD +0.77% Intraday chart for Arch Biopartners Inc. -6.83% +17.33%
Apr. 16 Arch Biopartners Says St. Michael's Hospital Joins Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-AKI MT
Apr. 16 Arch Biopartners Brief: Says St. Michael's Hospital Joins Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury MT

Turnover - Change in analysts' estimates

Turnover

  1. Stock Market
  2. Equities
  3. ACHFF Stock
  4. Revisions Arch Biopartners Inc.